COVID-19 is not going to disappear. The virus that causes it, SARS-CoV-2, has established itself permanently in human and animal populations, and every credible line of evidence points toward it becoming a long-term endemic infection, much like influenza. The World Health Organization ended its global public health emergency for COVID in May 2023, but the virus continues to circulate worldwide, causing seasonal waves of illness year after year.
That said, “not going away” doesn’t mean the situation stays frozen in 2020. The disease has already changed dramatically in severity for most people, and it will continue to evolve. Here’s what that future actually looks like.
What “Endemic” Really Means
When scientists say a virus becomes endemic, they mean it reaches a relatively stable level of circulation in the population. Instead of explosive, unpredictable surges, the virus settles into a pattern where roughly each infected person passes it to one other person on average. New susceptible people continually enter the picture through births, immigration, or waning immunity in those previously infected or vaccinated, so the virus always has somewhere to go.
This is different from eradication, where the virus is eliminated entirely (as with smallpox), or even from extinction, where it simply burns through a population and dies out. For COVID, waning immunity is the key factor. Protection from both vaccination and prior infection fades over months, which means new rounds of infection keep happening. That cycle of reinfection is what locks the virus into permanent circulation.
The good news is that endemic doesn’t mean equally dangerous. What matters most for long-term outcomes is that prior immunity, even when it no longer blocks infection, continues to protect against severe illness. That layer of protection is what separates a nuisance virus from a deadly one.
Why Eradication Is Off the Table
Only two human diseases have ever been eradicated: smallpox and rinderpest (a cattle disease). Both had characteristics COVID lacks. Three major barriers make eradicating SARS-CoV-2 essentially impossible.
First, the virus has animal reservoirs. Over five years of circulation, SARS-CoV-2 has been detected in white-tailed deer, mink, rats, hamsters, horses, cats, zoo animals, and dogs. White-tailed deer are the biggest concern: they show widespread natural infection, high rates of antibodies, and months of sustained deer-to-deer transmission across large regions. In some areas, deer still carry Alpha-like lineages long after those variants vanished from nearby human populations. These animals act as both amplifiers of active strains and cold storage for extinct ones, potentially seeding new variants back into humans.
Second, the virus mutates to dodge immunity. SARS-CoV-2 changes its genetic code at roughly two nucleotide substitutions per month, which is slower than many RNA viruses thanks to a built-in proofreading mechanism. But the mutations that matter most cluster in the spike protein, the part the immune system targets. The virus also has more sophisticated tricks: it can reduce the visibility of infected cells to immune defenses, coat itself in sugars made by the host’s own body to hide from antibodies, and even spread between cells through tiny tunnels that bypass immune surveillance entirely. New immune-escape variants frequently emerge in chronically infected or immunocompromised individuals who harbor the virus for months.
Third, global immunity is too uneven. Billions of people have varying levels of protection from different vaccines, different variants, and different timing of their last exposure. There is no realistic path to simultaneously immunizing the entire world population (plus animal reservoirs) against a virus that keeps changing its appearance.
COVID’s Emerging Seasonal Pattern
Since mid-2022, COVID has settled into a pattern of two waves per year in many parts of the world. The first wave typically begins in spring around May and peaks in summer. The second starts in October or November and peaks in winter. The winter peak follows the expected pattern for respiratory viruses, driven by cold weather, indoor crowding, and lower humidity. The summer peak is less intuitive but likely reflects the rapid waning of immunity acquired during the previous winter wave, combined with changes in social behavior during warmer months.
This double-peak pattern is one of the clearest signs that COVID is settling into a predictable rhythm, though it’s still more volatile than a fully mature seasonal virus like influenza.
How COVID Compares to the Flu Now
A common question is whether COVID has already become “just the flu.” The data says not yet, but the gap is closing. A large study of U.S. veterans tracked both diseases across recent seasons. During the 2022-2023 season, COVID’s hospitalization rate was about four times higher than influenza’s (63 vs. 15 per 100,000 people per month), and its death rate was roughly ten times higher (6.75 vs. 0.68 per 100,000). By the 2023-2024 season, COVID hospitalizations had dropped to about three times the flu rate (43 vs. 15 per 100,000), and deaths fell to roughly six times higher (4.48 vs. 0.79 per 100,000).
Then something notable happened. By February 2025, influenza-associated deaths actually exceeded COVID-associated deaths for the first time in that population, with flu killing at more than double the rate of COVID during that month. One month isn’t a trend, but it illustrates the trajectory: COVID is getting milder relative to flu season by season as population immunity deepens.
Long COVID Remains a Concern
Even as acute infections become less severe, lingering symptoms after infection continue to affect a significant number of people. CDC data from 2022 found that 6.9% of U.S. adults had experienced long COVID at some point, and 3.4% were dealing with it at the time they were surveyed. Symptoms range from fatigue and brain fog to heart palpitations and shortness of breath, sometimes lasting months or years. Whether reinfections carry the same risk of long-term symptoms as first infections is still being studied, but the sheer volume of ongoing infections means new cases of long COVID continue to accumulate.
How Vaccines and Surveillance Are Adapting
COVID vaccination is shifting toward an annual model similar to the flu shot. The CDC’s 2025-2026 guidance recommends one updated dose for people ages 6 months through 64, with the strongest emphasis on those at higher risk of severe disease. Adults 65 and older are recommended to receive two doses, spaced six months apart, reflecting their greater vulnerability. The approach is now framed around individual decision-making rather than blanket mandates, another sign of the transition to endemic management.
Current injectable vaccines are effective at preventing severe illness and death but do relatively little to stop transmission, because they don’t generate strong immunity in the nose and throat where the virus first takes hold. At least 28 nasal or oral COVID vaccines are currently in clinical trials, designed to trigger immune responses directly in the upper respiratory tract. If successful, these could reduce not just severe disease but actual spread of the virus, potentially dampening seasonal waves. Five mucosal vaccines have already been approved in various countries, though clinical data on most remains limited.
Meanwhile, wastewater surveillance has become one of the most valuable tools for tracking COVID’s movement through communities. By testing sewage, public health agencies can detect the virus shed by people who are presymptomatic, asymptomatic, or simply never tested. This system can identify emerging variants before they show up in hospital data, spot the early geographic spread of new lineages, and even flag novel variants not yet detected in any human clinical sample. It’s a cost-effective early warning system that works regardless of whether people seek medical care.
What the Long-Term Future Looks Like
The most likely scenario is that COVID follows the path of the four other human coronaviruses that circulate every year, causing common colds and occasional pneumonia in vulnerable groups. Those viruses were likely pandemic threats when they first entered the human population, possibly centuries ago, but they faded into the background as generation after generation built immunity from childhood exposure. COVID is on a compressed version of that timeline, aided by vaccines.
For most people, this means periodic reinfections that feel like a bad cold, punctuated by updated annual vaccines for those who want extra protection. For older adults and immunocompromised individuals, COVID will remain a serious seasonal threat requiring more aggressive prevention, much like influenza is today. The virus won’t vanish, but the crisis already has.